| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |